A team of DZL researchers has developed a novel tool to measure the activity of two proteins implicated in lung inflammation in cystic fibrosis.
DZL-Researchers have now succeeded in curing COPD in mice. Their goal is to test the novel therapeutic approach in human clinical trials over the next few years.
Children growing up on a farm have a lower risk of developing asthma than children not living on a farm. A group of researchers clarified how the children’s gut microbiome is involved in the protection...
DZL scientists published results on asthma diagnosis through breath analysis in the European Respiratory Journal. The results were disappointing, but the conclusions are important.
Dr. Stephan Rüller, Susanne Greve, Dr. Christian Herzmann and FLO-Medizintechnik were awarded with the Innovation Transfer Prize 2020 of the Werner Petersen Foundation.
It seems like a paradox that, of all things, a molecule which renders tumors resistant to can-cer medications also suppresses a mechanism that is vital for the survival of tumor cells. This is what Professor...
The German National Academy of Natural Sciences Leopoldina has appointed professors Martina Muckenthaler and Uwe Haberkorn, two DZL scientists, as members.
EMA, the European Medicines Agency, approved Kaftrio, a new triple-combination therapy for the treatment of cystic fibrosis.
Number of macrophages in tumor tissue enables prognosis of lung tumor progression.
DZL researchers have discovered a new stem cell state and been able to decode cellular hierarchy dur-ing alveolar regeneration following injury.
Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course. The immune system plays a decisive role.
Ursula Klingmüller was recognised for her outstanding scientific achievements by being elected as a Member of the European Molecular Biology Organisation (EMBO).
